Literature DB >> 23345409

Pharmacogenomics in the pocket of every patient? A prototype based on quick response codes.

Matthias Samwald1, Klaus-Peter Adlassnig.   

Abstract

A sizable fraction of patients experiences adverse drug events or lack of drug efficacy. A part of this variability in drug response can be explained by genetic differences between patients. However, pharmacogenomic data as well as computational clinical decision support systems for interpreting such data are still unavailable in most healthcare settings. We address this problem by introducing the medicine safety code (MSC), which captures compressed pharmacogenomic data in a two-dimensional barcode that can be carried in a patient's wallet. We successfully encoded data about 385 genetic polymorphisms in MSC and were able to decode and interpret MSC quickly with common mobile devices. The MSC could make individual pharmacogenomic data and decision support available in a wide variety of healthcare settings without the set up of large-scale infrastructures or centralized databases.

Entities:  

Mesh:

Year:  2013        PMID: 23345409      PMCID: PMC3628061          DOI: 10.1136/amiajnl-2012-001275

Source DB:  PubMed          Journal:  J Am Med Inform Assoc        ISSN: 1067-5027            Impact factor:   4.497


  14 in total

1.  Pharmacogenetics: from bench to byte.

Authors:  J J Swen; I Wilting; A L de Goede; L Grandia; H Mulder; D J Touw; A de Boer; J M H Conemans; T C G Egberts; O H Klungel; R Koopmans; J van der Weide; B Wilffert; H-J Guchelaar; V H M Deneer
Journal:  Clin Pharmacol Ther       Date:  2008-02-06       Impact factor: 6.875

2.  Towards an interoperable information infrastructure providing decision support for genomic medicine.

Authors:  Matthias Samwald; Holger Stenzhorn; Michel Dumontier; M Scott Marshall; Joanne Luciano; Klaus-Peter Adlassnig
Journal:  Stud Health Technol Inform       Date:  2011

3.  Warfarin genotyping reduces hospitalization rates results from the MM-WES (Medco-Mayo Warfarin Effectiveness study).

Authors:  Robert S Epstein; Thomas P Moyer; Ronald E Aubert; Dennis J O Kane; Fang Xia; Robert R Verbrugge; Brian F Gage; J Russell Teagarden
Journal:  J Am Coll Cardiol       Date:  2010-04-08       Impact factor: 24.094

Review 4.  From pharmacogenomic knowledge acquisition to clinical applications: the PharmGKB as a clinical pharmacogenomic biomarker resource.

Authors:  Ellen M McDonagh; Michelle Whirl-Carrillo; Yael Garten; Russ B Altman; Teri E Klein
Journal:  Biomark Med       Date:  2011-12       Impact factor: 2.851

5.  The feasibility of QR-code prescription in Taiwan.

Authors:  C-H Lin; F-Y Tsai; W-L Tsai; H-W Wen; M-L Hu
Journal:  J Clin Pharm Ther       Date:  2012-05-21       Impact factor: 2.512

Review 6.  Pharmacogenetics: from bench to byte--an update of guidelines.

Authors:  J J Swen; M Nijenhuis; A de Boer; L Grandia; A H Maitland-van der Zee; H Mulder; G A P J M Rongen; R H N van Schaik; T Schalekamp; D J Touw; J van der Weide; B Wilffert; V H M Deneer; H-J Guchelaar
Journal:  Clin Pharmacol Ther       Date:  2011-03-16       Impact factor: 6.875

Review 7.  Semantically enabling pharmacogenomic data for the realization of personalized medicine.

Authors:  Matthias Samwald; Adrien Coulet; Iker Huerga; Robert L Powers; Joanne S Luciano; Robert R Freimuth; Frederick Whipple; Elgar Pichler; Eric Prud'hommeaux; Michel Dumontier; M Scott Marshall
Journal:  Pharmacogenomics       Date:  2012-01       Impact factor: 2.533

8.  Codeine intoxication associated with ultrarapid CYP2D6 metabolism.

Authors:  Yvan Gasche; Youssef Daali; Marc Fathi; Alberto Chiappe; Silvia Cottini; Pierre Dayer; Jules Desmeules
Journal:  N Engl J Med       Date:  2004-12-30       Impact factor: 91.245

Review 9.  Implementing personalized medicine: development of a cost-effective customized pharmacogenetics genotyping array.

Authors:  J A Johnson; B M Burkley; T Y Langaee; M J Clare-Salzler; T E Klein; R B Altman
Journal:  Clin Pharmacol Ther       Date:  2012-08-22       Impact factor: 6.875

10.  Linked open drug data for pharmaceutical research and development.

Authors:  Matthias Samwald; Anja Jentzsch; Christopher Bouton; Claus Stie Kallesøe; Egon Willighagen; Janos Hajagos; M Scott Marshall; Eric Prud'hommeaux; Oktie Hassenzadeh; Elgar Pichler; Susie Stephens
Journal:  J Cheminform       Date:  2011-05-16       Impact factor: 5.514

View more
  8 in total

1.  Implementation of a clinical research pharmacogenomics program at an academic medical center: role of the genetics healthcare professional.

Authors:  Amy Curry Sturm; Kevin Sweet; Kandamurugu Manickam
Journal:  Pharmacogenomics       Date:  2013-05       Impact factor: 2.533

2.  An ontology-based, mobile-optimized system for pharmacogenomic decision support at the point-of-care.

Authors:  Jose Antonio Miñarro-Giménez; Kathrin Blagec; Richard D Boyce; Klaus-Peter Adlassnig; Matthias Samwald
Journal:  PLoS One       Date:  2014-05-02       Impact factor: 3.240

3.  Pharmacogenomic knowledge representation, reasoning and genome-based clinical decision support based on OWL 2 DL ontologies.

Authors:  Matthias Samwald; Jose Antonio Miñarro Giménez; Richard D Boyce; Robert R Freimuth; Klaus-Peter Adlassnig; Michel Dumontier
Journal:  BMC Med Inform Decis Mak       Date:  2015-02-22       Impact factor: 2.796

4.  Incidence of Exposure of Patients in the United States to Multiple Drugs for Which Pharmacogenomic Guidelines Are Available.

Authors:  Matthias Samwald; Hong Xu; Kathrin Blagec; Philip E Empey; Daniel C Malone; Seid Mussa Ahmed; Patrick Ryan; Sebastian Hofer; Richard D Boyce
Journal:  PLoS One       Date:  2016-10-20       Impact factor: 3.240

5.  Examining perceptions of the usefulness and usability of a mobile-based system for pharmacogenomics clinical decision support: a mixed methods study.

Authors:  Kathrin Blagec; Katrina M Romagnoli; Richard D Boyce; Matthias Samwald
Journal:  PeerJ       Date:  2016-02-08       Impact factor: 2.984

6.  Qualitative user evaluation of a revised pharmacogenetic educational toolkit.

Authors:  Rachel Mills; Susanne B Haga
Journal:  Pharmgenomics Pers Med       Date:  2018-09-04

Review 7.  Pharmacogenomic testing in paediatrics: Clinical implementation strategies.

Authors:  Charlotte I S Barker; Gabriella Groeneweg; Anke H Maitland-van der Zee; Michael J Rieder; Daniel B Hawcutt; Tim J Hubbard; Jesse J Swen; Bruce C Carleton
Journal:  Br J Clin Pharmacol       Date:  2022-02-07       Impact factor: 3.716

8.  Making data on essential pharmacogenes available for every patient everywhere: the Medicine Safety Code initiative.

Authors:  Matthias Samwald; Robert R Freimuth
Journal:  Pharmacogenomics       Date:  2013-10       Impact factor: 2.533

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.